COVID-19 Public Health Emergency Ends in the U.S., but Need to Ensure Access to Quality Assured Vaccines Remains
USP builds upon COVID Learnings about Stakeholder Collaboration, Supply Chain Vulnerabilities and Quality Standards to Meet Future Vaccine Demand